A critical breakthrough in cancer study is arising with the use of nanobodies to re-engage damaged p53. This essential cancer protector protein is frequently inactivated in various types of cancer, causing uncontrolled https://sitesrow.com/story12015505/nanobodies-reactivate-p53-the-potential-approach-for-malignant-therapy